Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-207342
Abstract: Introduction: Treatment options for myelodysplastic syndrome (MDS) are dependent on individual disease characteristics and impact patient prognosis and healthcare resource utilization (HCRU). Specifically, higher-risk MDS (HR-MDS) treatment involves a range of interventions, which can be… read more here.
Keywords: hcru; year hcru; hcru costs; management ... See more keywords